Predict your next investment

ProteoWise company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Series B | Alive

Total Raised


Last Raised

$2.65M | 5 mos ago

About ProteoWise

ProetoWise developed a 3-dimensional nanoscale protein capture. By binding proteins covalently in rigid nanoporous structures, 3-dimensional nanoscale protein capture can be rapidly and repeatedly addressed with antibody probes. This solves all the problems of western blot while providing molecular weight and identity information that researchers need.

ProteoWise Headquarter Location

34 Bryan Road

Branford, Connecticut, 06405,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ProteoWise

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ProteoWise is included in 1 Expert Collection, including Nanobiotechnology.



707 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.